Chemoinformaics analysis of 2-Methoxy-1,4-naphthoquinone
| Molecular Weight | 188.182 | nRot | 1 |
| Heavy Atom Molecular Weight | 180.118 | nRig | 13 |
| Exact Molecular Weight | 188.047 | nRing | 2 |
| Solubility: LogS | -3.035 | nHRing | 0 |
| Solubility: LogP | 1.595 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 26.1103 |
| nHD | 0 | BPOL | 11.4977 |
| QED | 0.672 |
| Synth | 2.012 |
| Natural Product Likeliness | 1.309 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.094 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.468 |
| MDCK | 0.0000248 |
| BBB | 0.304 |
| PPB | 0.906909 |
| VDSS | 0.611 |
| FU | 0.0195456 |
| CYP1A2-inh | 0.981 |
| CYP1A2-sub | 0.906 |
| CYP2c19-inh | 0.889 |
| CYP2c19-sub | 0.196 |
| CYP2c9-inh | 0.673 |
| CYP2c9-sub | 0.714 |
| CYP2d6-inh | 0.736 |
| CYP2d6-sub | 0.333 |
| CYP3a4-inh | 0.343 |
| CYP3a4-sub | 0.195 |
| CL | 5.16 |
| T12 | 0.609 |
| hERG | 0.017 |
| Ames | 0.904 |
| ROA | 0.912 |
| SkinSen | 0.877 |
| Carcinogencity | 0.889 |
| EI | 0.979 |
| Respiratory | 0.414 |
| NR-Aromatase | 0.143 |
| Antiviral | No |
| Prediction | 0.625772 |